missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human RBMY1F (aa 414-470) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (41%), Rat (41%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-62740 (PA5-62740. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
This gene encodes a protein containing an RNA-binding motif in the N-terminus and four SRGY (serine, arginine, glycine, tyrosine) boxes in the C-terminus. Multiple copies of this gene are found in the AZFb azoospermia factor region of chromosome Y and the encoded protein is thought to be involved in spermatogenesis. Most copies of this locus are pseudogenes, although six highly similar copies have full-length ORFs and are considered functional. Four functional copies of this gene are found within inverted repeat IR2; two functional copies of this gene are found in palindrome P3, along with two copies of PTPN13-like, Y-linked.
Specifications
Specifications
| Accession Number | Q15415 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 159163 |
| Name | Human RBMY1F (aa 414-470) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | RBMY1F; RBMY1J; RNA binding motif protein, Y-linked, family 1, member F; RNA-binding motif protein, Y chromosome, family 1 member F/J; Y chromosome RNA recognition motif 2; YRRM2 |
| Common Name | RBMY1F |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction